Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 244741000001111 | Velmanase alfa | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 244751000001114 | Velmanase alfa (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Velmanase alfa | Is a | Alpha-mannosidase | true | Inferred relationship | Existential restriction modifier | ||
| Velmanase alfa | Is a | Recombinant protein | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Velmanase alfa 10mg powder for solution for infusion vials | Has specific active ingredient | True | Velmanase alfa | Inferred relationship | Existential restriction modifier | |
| Lamzede 10mg powder for solution for infusion vials (Chiesi Ltd) | Has specific active ingredient | True | Velmanase alfa | Inferred relationship | Existential restriction modifier | |
| Velmanase alfa 10mg powder for solution for infusion vials 1 vial | Has specific active ingredient | True | Velmanase alfa | Inferred relationship | Existential restriction modifier | |
| Lamzede 10mg powder for solution for infusion vials (Chiesi Ltd) 1 vial | Has specific active ingredient | True | Velmanase alfa | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR